Načítá se...
Warfarin therapy in atrial fibrillation: assessment of patient knowledge of risks and benefits
Patients with atrial fibrillation are at an increased risk for stroke, and many benefits from anticoagulation. Despite the emergence of direct oral anticoagulants, many patients continue to rely on warfarin for their anticoagulation due to logistical, pharmacokinetic, clinical, or patient preference...
Uloženo v:
| Vydáno v: | J Community Hosp Intern Med Perspect |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7426993/ https://ncbi.nlm.nih.gov/pubmed/32850062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20009666.2020.1767270 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|